Drugmakers in Russia eye more active cooperation with medical personnel

22 October 2019
russia_lake_stock_large

Leading domestic and global pharmaceutical producers operating in the Russian market plan to expand their cooperation with local medical personnel during the promotion of their drugs in Russia, by organizing more scientific conferences, and active invitation of doctors to participate in them, according to recent statements by drugmakers and industry analysts, reports The Pharma Letter’s local correspondent.

As representatives of producers have said, currently the growth of sales of their drugs in the Russian pharmaceutical retail sector remain at a minimum level, with one of the reasons for this being poor activities for the promotion of their drugs by Russian pharmacies. This is despite the bonuses which are currently paid by producers to them.

Currently manufacturers pay pharmacies for shelving, as well as priority consumer advice and other services that do not guarantee sales. In recent years, drug sales in Russian pharmacies have significantly slowed down, which has forced producers to think about cutting at least part of their costs allocated for the promotion of drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical